Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 2.7.7.49 extracted from

  • Lin, X.; Ma, Z.M.; Yao, X.; He, L.F.; Yuan, Z.H.; Ding, J.P.; Wen, Y.M.
    Substitution of proline 306 in the reverse transcriptase domain of hepatitis B virus regulates replication (2005), J. Gen. Virol., 86, 85-90.
    View publication on PubMed

Protein Variants

Protein Variants Comment Organism
P306A replication competency is reduced to 12.75% of the wild-type value Hepatitis B virus
P306D replication competency is increased to 121.57% of the wild-type value Hepatitis B virus
P306E replication competency is increased to 940.59% of the wild-type value Hepatitis B virus
P306F replication competency is reduced to 41.18% of the wild-type value Hepatitis B virus
P306G replication competency is reduced to 1.96% of the wild-type value Hepatitis B virus
P306L replication competency is increased to 128.04% of the wild-type value Hepatitis B virus
P306R replication competency is reduced to 20.26% of the wild-type value Hepatitis B virus
P306S replication competency is reduced to 47.25% of the wild-type value Hepatitis B virus
P306T replication competency is reduced to 4.5% of the wild-type value Hepatitis B virus
P306V replication competency is increased to 152.75% of the wild-type value Hepatitis B virus
P306Y replication competency is reduced to 10.98% of the wild-type value Hepatitis B virus

Organism

Organism UniProt Comment Textmining
Hepatitis B virus
-
-
-

Substrates and Products (Substrate)

Substrates Comment Substrates Organism Products Comment (Products) Rev. Reac.
deoxynucleoside triphosphate + DNAn
-
Hepatitis B virus diphosphate + DNAn+1
-
?